+254 773 977 440 info@nltp.co.ke

Global Fund



The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) was created to dramatically increase resources to fight three of the world’s most devastating diseases, and to direct those resources to areas of greatest need. As a partnership between governments, civil society, the private sector and affected communities, the Global Fund represents an innovative approach to international health financing.

GFATM Support to the Kenya

Kenya is among the beneficiaries of the GFATM. Under the Tuberculosis component, the country has benefited from the round 2, 5 and 6 below is summary of the impact of the utilization of the GFATM funds.

Impact of global fund in Kenya

Round Amount budgeted (USD) Amount received (%) (USD) Amount spent
Life span remaining
2 8,623,253 3,556,121(41) 2,276,291(64) 1 year
5 19,899,621 3,511,242(17.6) 2,162,607(61) 4 years
6 26,964,867 Nil Nil 5 years

This support has enabled the division of TB and leprosy control to carry out the following activities

  1. Provide transport to facilitate distribution of drugs and supervision of treatment for the two diseases
  2. Capacity building of staffs providing TB services to enable them to offer new TB packages especially TBHIV services, community involvement in TB control and in monitoring and evaluation
  3. Support commodity security in terms of procurement of Cortimoxazole, laboratory reagents and first line and second line anti-TB drugs
  4. To support mass media and community social mobilization for TB control

The main achievements  

Activity Specific item Achievements
Provision of transport Vehicles 8 vehicles procured
Bicycles 780 bicycles procured
Motor bikes 15 motor bikes procured
Training Health care workers 2,541health workers trained
Community health care workers
1,182 CHWs trained
New initiatives supported TBHIV programme Rolled out country wide. Now 79% of our patients access TBHIV services
Community DOTS Programme rolled out in 31 districts
Purchase of TB drugs First line 40,000 anti-TB patient packs bought
Second line Drugs for 40 MDRTB patients purchased
Cortimoxazole Cortimoxazole available
Laboratory support Renovation of laboratories 13 laboratories renovated and in use
Microscopes 100 microscopes bought
Reagents Lab reagents procured in 2005, 2006 and 2007
Advocacy Mass media TV  and radio campaigns in 2004, 2005 and 2007
Sensitization of local leaders 1,753 leaders sensitized